The reasons behind the lack of prognostic value for HER2-positive breast cancer in this study are unclear, whether it is due to small sample size with few events, the detection range of the assay, or the biology of the disease, so further investigation is warranted. This evidence concerns the gene ERBB2 and breast cancer.